|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Other receivables | |||||||||||||||
| Marketable securities | |||||||||||||||
| Accounts receivable | |||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Investments held in Trust Account | |||||||||||||||
| Deferred offering costs | |||||||||||||||
| Restricted cash | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||
| Due to related party | |||||||||||||||
| Related Party | |||||||||||||||
| Total due to related party | |||||||||||||||
| Extension note | |||||||||||||||
| Related Party | |||||||||||||||
| Total extension note | |||||||||||||||
| Working capital loan | |||||||||||||||
| Operating lease liabilities, current | |||||||||||||||
| Debt, current portion | |||||||||||||||
| Second lien loans | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred financing obligation | |||||||||||||||
| Debt, net of current portion | |||||||||||||||
| Second lien loans | |||||||||||||||
| Liabilities, redeemable convertible preferred stock and stockholders’ deficit | |||||||||||||||
| Debt, net of current portion | |||||||||||||||
| Deferred underwriting and advisory fees | |||||||||||||||
| Simple agreements for future equity | |||||||||||||||
| Operating lease liabilities, noncurrent | |||||||||||||||
| Common stock warrants | |||||||||||||||
| Other liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Class A ordinary shares subject to possible redemption as of December 31, 2024 | |||||||||||||||
| Redeemable convertible preferred stock | |||||||||||||||
| Series A Cumulative Convertible Preferred Stock | |||||||||||||||
| Cumulative redeemable convertible preferred stock | |||||||||||||||
| Total redeemable convertible preferred stock | |||||||||||||||
| Stockholders’ deficit | |||||||||||||||
| Preference shares, $0.0001 par value; 99,990,000 shares authorized; none issued or outstanding | |||||||||||||||
| Common stock, $0.0001 par value; 1,980,000 shares authorized; 196,3641 and 175,4401 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||||||||
| Common Class A | |||||||||||||||
| Common Class B | |||||||||||||||
| Total common stock, $0.0001 par value; 1,980,000 shares authorized; 196,3641 and 175,4401 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total stockholders’ deficit | |||||||||||||||
| Total liabilities, redeemable convertible preferred stock and stockholders’ deficit | |||||||||||||||
| Redemption price (in dollars per share) | |||||||||||||||
| Outstanding shares subject to redemption (in shares) | |||||||||||||||
| Common Class A | |||||||||||||||
| Series A Cumulative Convertible Preferred Stock | |||||||||||||||
| Cumulative redeemable convertible preferred stock | |||||||||||||||
| Total outstanding shares subject to redemption (in shares) | |||||||||||||||
Loading...